Civic AI
Procurement intelligence
Federal contract award
TO ADVANCE THE DEVELOPMENT OF THE SHIGETEC VACCINE THROUGH CGMP MANUFACTURING AND RELEASE OF ADDITIONAL CGMP LOTS FOR USE IN A SERIES OF PHASE 2 CLINICAL TRIALS.
EVELIQURE BIOTECHNOLOGIES GMBH · Department of Health and Human Services
- Value
- $11,480,630
- Start
- Sep 1, 2020
- End
- Mar 31, 2027
- Action date
- Mar 31, 2026
- PIID
- 75N93020C00048
- Status
- active
- NAICS
- 541715 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
- Place of performance
- —
- Award type
- DEFINITIVE CONTRACT
Description
TO ADVANCE THE DEVELOPMENT OF THE SHIGETEC VACCINE THROUGH CGMP MANUFACTURING AND RELEASE OF ADDITIONAL CGMP LOTS FOR USE IN A SERIES OF PHASE 2 CLINICAL TRIALS.
Need modifications, related awards, and vendor peers? Open the full award workspace.